Partnering Science for Impact
Joslin Technologies is an accelerator that designs and delivers solutions to industry by leveraging Joslin’s expertise and infrastructure in cellular assays, knock-out animal models, unique cell lines for screening of drug candidates or validation of biomarkers.
We also conduct clinical studies for the drug and device industry using the diabetes-specific patient access. The availability of biobanks of samples and data on diabetes complications allows ease of validation and a path to the clinic.
Our research services are conducted in a dedicated laboratory space to provide documentation and data in order to facilitate regulatory readiness and submissions by our clients.
News | Joslin Research
Page last updated: December 21, 2014